Yokoe Masamichi, Takada Tadahiro, Mayumi Toshihiko, Yoshida Masahiro, Isaji Shuji, Wada Keita, Itoi Takao, Sata Naohiro, Gabata Toshifumi, Igarashi Hisato, Kataoka Keisho, Hirota Masahiko, Kadoya Masumi, Kitamura Nobuya, Kimura Yasutoshi, Kiriyama Seiki, Shirai Kunihiro, Hattori Takayuki, Takeda Kazunori, Takeyama Yoshifumi, Hirota Morihisa, Sekimoto Miho, Shikata Satoru, Arata Shinju, Hirata Koichi
General Internal Medicine, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
J Hepatobiliary Pancreat Sci. 2015 Jun;22(6):405-32. doi: 10.1002/jhbp.259. Epub 2015 May 13.
Japanese (JPN) guidelines for the management of acute pancreatitis were published in 2006. The severity assessment criteria for acute pancreatitis were later revised by the Japanese Ministry of Health, Labour and Welfare (MHLW) in 2008, leading to their publication as the JPN Guidelines 2010. Following the 2012 revision of the Atlanta Classifications of Acute Pancreatitis, in which the classifications of regional complications of pancreatitis were revised, the development of a minimally invasive method for local complications of pancreatitis spread, and emerging evidence was gathered and revised into the JPN Guidelines.
A comprehensive evaluation was carried out on the evidence for epidemiology, diagnosis, severity, treatment, post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and clinical indicators, based on the concepts of the GRADE system (Grading of Recommendations Assessment, Development and Evaluation). With the graded recommendations, where the evidence was unclear, Meta-Analysis team for JPN Guidelines 2015 conducted an additional new meta-analysis, the results of which were included in the guidelines.
Thirty-nine questions were prepared in 17 subject areas, for which 43 recommendations were made. The 17 subject areas were: Diagnosis, Diagnostic imaging, Etiology, Severity assessment, Transfer indication, Fluid therapy, Nasogastric tube, Pain control, Antibiotics prophylaxis, Protease inhibitor, Nutritional support, Intensive care, management of Biliary Pancreatitis, management of Abdominal Compartment Syndrome, Interventions for the local complications, Post-ERCP pancreatitis and Clinical Indicator (Pancreatitis Bundles 2015). Meta-analysis was conducted in the following four subject areas based on randomized controlled trials: (1) prophylactic antibiotics use; (2) prophylactic pancreatic stent placement for the prevention of post-ERCP pancreatitis; (3) prophylactic non-steroidal anti-inflammatory drugs (NSAIDs) for the prevention of post-ERCP pancreatitis; and (4) peritoneal lavage. Using the results of the meta-analysis, recommendations were graded to create useful information. In addition, a mobile application was developed, which made it possible to diagnose, assess severity and check pancreatitis bundles.
The JPN Guidelines 2015 were prepared using the most up-to-date methods, and including the latest recommended medical treatments, and we are confident that this will make them easy for many clinicians to use, and will provide a useful tool in the decision-making process for the treatment of patients, and optimal medical support. The free mobile application and calculator for the JPN Guidelines 2015 is available via http://www.jshbps.jp/en/guideline/jpn-guideline2015.html.
日本急性胰腺炎管理指南于2006年发布。急性胰腺炎的严重程度评估标准随后于2008年由日本厚生劳动省(MHLW)修订,最终作为《2010年日本指南》发布。继2012年修订《急性胰腺炎亚特兰大分类》(其中胰腺炎区域并发症的分类有所修订)之后,针对胰腺炎局部并发症的微创治疗方法得到推广,新收集的证据经整理后纳入《日本指南》。
基于推荐分级的评估、制定与评价(GRADE)系统的理念,对流行病学、诊断、严重程度、治疗、内镜逆行胰胆管造影(ERCP)术后胰腺炎及临床指标等方面的证据进行了全面评估。对于证据不明确的分级推荐,《2015年日本指南》的Meta分析团队进行了一项新的Meta分析,其结果被纳入指南。
在17个主题领域准备了39个问题,并给出了43条推荐意见。这17个主题领域分别为:诊断、诊断性影像学、病因、严重程度评估、转运指征、液体治疗、鼻胃管、疼痛控制、抗生素预防、蛋白酶抑制剂、营养支持、重症监护、胆源性胰腺炎的管理、腹腔间隔室综合征的管理、局部并发症的干预、ERCP术后胰腺炎及临床指标(2015年胰腺炎集束指标)。基于随机对照试验,在以下四个主题领域进行了Meta分析:(1)预防性使用抗生素;(2)预防性放置胰管支架以预防ERCP术后胰腺炎;(3)预防性使用非甾体抗炎药(NSAIDs)以预防ERCP术后胰腺炎;(4)腹腔灌洗。利用Meta分析结果对推荐意见进行分级,以提供有用信息。此外,还开发了一款移动应用程序,可用于诊断、评估严重程度及查看胰腺炎集束指标。
《2015年日本指南》采用了最新方法编制,纳入了最新推荐的医学治疗措施,我们相信这将使众多临床医生易于使用,并为患者治疗决策过程及优化医疗支持提供有用工具。可通过http://www.jshbps.jp/en/guideline/jpn-guideline2015.html获取免费的《2015年日本指南》移动应用程序和计算器。